Peer-reviewedCC BYFrontiers in aging neuroscience
Dexmedetomidine as a potential neuroprotective agent against Alzheimer’s disease: molecular mechanisms and therapeutic perspectives
- 1First Clinical Medical College of Lanzhou University , ,
- 2Department of Anesthesiology, Gansu Provincial Hospital , ,
- 3Institute of Clinical Research and Translational Medicine, Gansu Provincial Hospital , ,
Related
- The Role of Herbal Medicines in Cognitive Impairment: A Narrative Review of Neuroprotective Mechanisms and Therapeutic Perspectives
- MiR-532 as a Potential Therapeutic Target and Biomarker: Biological Functions, Molecular Mechanisms, and Clinical Perspectives.
- Gut microbiota as a potential mediator of the disease-ameliorating effects of molecular hydrogen: mechanisms and therapeutic perspectives
- Targeting the NLRP3 inflammasome in rheumatoid arthritis fibroblast-like synoviocytes: pathogenic mechanisms, therapeutic strategies, and translational perspectives
- Cuproptosis in glioma: mechanisms, biological roles and therapeutic perspectives
BibTeX
@article{kang2026dexmedetomidine,
title = {{Dexmedetomidine as a potential neuroprotective agent against Alzheimer’s disease: molecular mechanisms and therapeutic perspectives}},
author = {Jun Kang and Yongbo Duan and Jiaxuan Bi and Jiangping Liu and Wenjun Yan},
journal = {Frontiers in aging neuroscience},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13673236},
note = {CC BY},
}
RIS
TY - JOUR
TI - Dexmedetomidine as a potential neuroprotective agent against Alzheimer’s disease: molecular mechanisms and therapeutic perspectives
AU - Jun Kang
AU - Yongbo Duan
AU - Jiaxuan Bi
AU - Jiangping Liu
AU - Wenjun Yan
PY - 2026
DA - 2026/10/19
JO - Frontiers in aging neuroscience
UR - https://europepmc.org/article/PMC/PMC13673236
SN - 1663-4365
ER -